Literature DB >> 18782401

General practitioners' knowledge and attitudes to contact tracing for genital Chlamydia trachomatis infection in North Queensland.

Clare Heal1, Rosanne Muller.   

Abstract

INTRODUCTION: Most diagnoses of genital chlamydia infection in Queensland are made by general practitioners (GPs). This study aimed to assess GP attitudes to and knowledge of contact tracing in rural North Queensland.
METHOD: A single page questionnaire mailed to a database of 65 GPs in May 2007.
RESULTS: Nearly all respondents (42/43, 97.7%) 'always' or 'mostly' told patients to advise their contacts to seek medical treatment. More than half (24/44, 54.5%) felt that contact tracing was 'sometimes' or 'never' the responsibility of GPs. Around half of respondents (19/39, 48.7%) thought that the local public health unit staff were conducting contact tracing, which is not actually the case.
CONCLUSION: There is lack of clarity surrounding the respective roles and responsibilities of sexual health units, public health units and GPs regarding contact tracing for chlamydia infection. IMPLICATIONS: GPs would benefit from education clarifying current contact tracing procedures, methods and resources.

Entities:  

Mesh:

Year:  2008        PMID: 18782401     DOI: 10.1111/j.1753-6405.2008.00256.x

Source DB:  PubMed          Journal:  Aust N Z J Public Health        ISSN: 1326-0200            Impact factor:   2.939


  2 in total

1.  Contact heterogeneity and phylodynamics: how contact networks shape parasite evolutionary trees.

Authors:  Eamon B O'Dea; Claus O Wilke
Journal:  Interdiscip Perspect Infect Dis       Date:  2010-12-01

2.  Better than nothing? Patient-delivered partner therapy and partner notification for chlamydia: the views of Australian general practitioners.

Authors:  Natasha L Pavlin; Rhian M Parker; Anna K Piggin; Carol A Hopkins; Meredith J Temple-Smith; Christopher K Fairley; Jane E Tomnay; Francis J Bowden; Darren B Russell; Jane S Hocking; Marian K Pitts; Marcus Y Chen
Journal:  BMC Infect Dis       Date:  2010-09-20       Impact factor: 3.090

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.